• RITA (NSC 652287) Assay Workflows

  2026-08-11

  RITA (NSC 652287) enables a focused way to probe MDM2-p53 signaling, DNA cross-link-associated stress, and selective tumor-cell responses. This workflow pairs dose–response testing with separate growth and cell-death measurements so renal carcinoma research does not confuse proliferation arrest with true killing.

• CGRP/SP–Piezo2 Signaling in Trigeminal Allodynia

  2026-08-10

  Liao et al. identify a Ca2+-dependent CGRP/SP–Piezo2 feedback loop linking trigeminal root compression, neuroinflammation, and mechanical allodynia. Their rat and cell-based experiments position the TG neuron–Merkel cell axis as a mechanistic bridge between ATP signaling, PKC/MAPK activation, and abnormal facial mechanosensitivity.

• Puerarin Activates NO Signaling in Dental Follicle Cells

  2026-08-09

  The reference study shows that puerarin enhances osteogenic differentiation in rat dental follicle cells while increasing nitric oxide, cGMP, and osteogenic markers. Pharmacological inhibition with L-NMMA reverses these effects, supporting a mechanistic role for nitric oxide pathway activation in periodontal tissue regeneration research.

• FPR2/ALX Modulates Microglia in Astrocytopathy

  2026-08-08

  The reference study identifies FPR2/ALX stimulation with Quin-C1 as a means of limiting autoimmune astrocytopathy by altering microglial and natural killer cell activity. Its depletion and pathway-inhibition experiments connect the protective phenotype to immune-cell regulation and, at least partly, SYK-AKT signaling, providing a mechanistic framework for further CNS autoimmunity research.

• Nutlin-3a: Decoding p53 Death in Glioblastoma

  2026-08-07

  Nutlin-3a is a potent MDM2 inhibitor for dissecting p53 pathway activation, cell cycle arrest, and apoptosis induction. This article adds a distinct assay-design perspective by separating apoptosis from ferroptosis when studying glioblastoma biology.

• Pifithrin-α: Strategic p53 Inhibition for Translational Neur

  2026-08-07

  Explore how Pifithrin-α (PFTα) empowers translational researchers to dissect and control p53-mediated apoptosis and ferroptosis, with mechanistic insights from recent neurotoxicology studies and actionable protocol guidance for optimizing experimental design and translational impact. This article integrates current scientific evidence, highlights competitive best practices, and envisions future directions for leveraging p53 inhibition in the mitigation of neurodegeneration and cancer therapy side effects.

• RITA (NSC 652287): Applied Workflows in Renal Carcinoma Rese

  2026-08-06

  RITA (NSC 652287) is a potent MDM2-p53 interaction inhibitor enabling precise cancer biology workflows, from apoptosis assays to in vivo tumor regression models. This article provides actionable protocols, troubleshooting strategies, and interprets new in vitro evaluation paradigms to help researchers maximize RITA's translational impact.

• EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1

  2026-08-06

  EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) is a water-soluble carbodiimide reagent that enables efficient amide bond formation in peptide synthesis, bioconjugation, and nucleotide coupling workflows. It is not suitable for in vivo or clinical use, and should be restricted to controlled, in vitro applications where precise carboxyl-to-amine coupling is required.

• EdU Flow Cytometry Assay Kits (Cy5): Advanced S-Phase Detect

  2026-08-05

  EdU Flow Cytometry Assay Kits (Cy5) enable high-sensitivity, denaturation-free quantification of S-phase DNA synthesis using click chemistry for robust cell proliferation analysis. Their compatibility with multiplexed antibody staining and gentle fixation protocols gives researchers a flexible edge for cancer and immunology studies.

• Tomivosertib Suppresses Spontaneous Activity in Human DRG Ne

  2026-08-05

  The reference study presents the first direct evidence that tomivosertib, a selective MNK inhibitor, rapidly and reversibly suppresses spontaneous ectopic activity in cultured human dorsal root ganglion (DRG) neurons from patients with radiculopathic pain. This work establishes a mechanistic rationale for targeting MNK signaling in neuropathic pain and sets a translational foundation for future clinical trials.

• MG-262 (Z-Leu-Leu-Leu-B(OH)2): Selective Proteasome Inhibiti

  2026-08-04

  MG-262 (Z-Leu-Leu-Leu-B(OH)2) is a potent, reversible, and cell-permeable proteasome inhibitor widely employed in apoptosis and cell cycle arrest studies. Its precise inhibition of chymotryptic proteasome activity enables benchmarked workflows in proteostasis research. Quantitative performance and protocol integration details are supported by peer-reviewed and product documentation.

• Isoprinosine (Inosine Pranobex): Immunomodulatory Mechanisms

  2026-08-04

  Isoprinosine, also known as inosine pranobex, is a water-soluble immunomodulator with verified efficacy in inhibiting viral replication and enhancing immune parameters in murine and human models. Its mechanisms include modulation of leukocyte function and potentiation of interferon-based antiviral responses. This article details mechanistic rationale, benchmark evidence, and practical workflow guidance for Isoprinosine use.

• Rucaparib (AG-014699): Mechanistic Insights Beyond DNA Repai

  2026-08-03

  Explore the advanced mechanistic landscape of Rucaparib (AG-014699), a potent PARP1 inhibitor, with a focus on spliceosome regulation and radiosensitization in cancer research. Gain new perspectives on assay design and therapeutic innovation.

• Cyclic Pifithrin-α Hydrobromide: Unveiling p53 Inhibition Be

  2026-08-03

  Explore Cyclic Pifithrin-α hydrobromide as a p53 inhibitor with unique potential in modulating apoptosis and neuroinflammatory pathways. This in-depth article reveals novel cross-domain insights for assay design and translational research.

• Butylhydroxyanisole (BHA): Structural and Functional Precisi

  2026-08-02

  Explore how Butylhydroxyanisole (BHA) enables high-fidelity oxidative stress research, with a focus on its structural advantages, assay optimization, and implications for peptide-based discovery. This article uniquely connects BHA's molecular design to experimental reproducibility, distinguishing it from protocol-centric guides.

8695 records 10/580 page Previous Next First page 上5页 678910 下5页 Last page